Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Raw Materials: 2016-2019

Historic Raw Materials for Ironwood Pharmaceuticals (IRWD) over the last 1 years, with Dec 2019 value amounting to $65,000.

  • Ironwood Pharmaceuticals' Raw Materials was N/A to $65,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $65,000, marking a year-over-year change of. This contributed to the annual value of $65,000 for FY2019, which is N/A change from last year.
  • As of Q4 2019, Ironwood Pharmaceuticals' Raw Materials stood at $65,000, which was down 94.27% from $1.1 million recorded in Q3 2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Raw Materials ranged from a high of $1.5 million in Q1 2017 and a low of $65,000 during Q4 2019.
  • Its 3-year average for Raw Materials is $770,857, with a median of $593,000 in 2019.
  • Its Raw Materials has fluctuated over the past 5 years, first tumbled by 79.64% in 2018, then skyrocketed by 378.90% in 2019.
  • Ironwood Pharmaceuticals' Raw Materials (Quarterly) stood at $1.0 million in 2016, then reached $1.5 million in 2017, then plummeted by 79.64% to $308,000 in 2018, then skyrocketed by 378.90% to $65,000 in 2019.
  • Its Raw Materials stands at $65,000 for Q4 2019, versus $1.1 million for Q3 2019 and $1.5 million for Q2 2019.